TY  - GEN
AU  - Saito,Takefumi
AU  - Takeda,Akinori
AU  - Hashimoto,Katsuji
AU  - Kobayashi,Akihiro
AU  - Hayamizu,Tomoyuki
AU  - Hagan,Gerald W
TI  - Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE
SN  - 1178-2005
PY  - 2016///0920
KW  - Administration, Inhalation
KW  - Adrenergic beta-2 Receptor Agonists
KW  - administration & dosage
KW  - Aged
KW  - Area Under Curve
KW  - Bronchodilator Agents
KW  - Cholinergic Antagonists
KW  - Cross-Over Studies
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluticasone-Salmeterol Drug Combination
KW  - Forced Expiratory Volume
KW  - Humans
KW  - Japan
KW  - Lung
KW  - drug effects
KW  - Male
KW  - Middle Aged
KW  - Nebulizers and Vaporizers
KW  - Plethysmography
KW  - Predictive Value of Tests
KW  - Pulmonary Disease, Chronic Obstructive
KW  - diagnosis
KW  - ROC Curve
KW  - Recovery of Function
KW  - Severity of Illness Index
KW  - Spirometry
KW  - Time Factors
KW  - Tiotropium Bromide
KW  - Treatment Outcome
KW  - Vital Capacity
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2147/COPD.S89948
ER  -